In a mid-stage trial, nearly three-quarters of patients experienced nausea, nearly half experienced vomiting, and an much as a quarter experienced diarrhea numbers the company considered too high to convince people to take its drug twice every day
Common causes include gallstones, excessive alcohol consumption, certain medications, hypertriglyceridaemia, and anatomical abnormalities
What the Research Shows About Oral Semaglutide The FDA approval is based on results from the OASIS 4 clinical trial published in the New England Journal of Medicine
The most frequent issues were nausea , vomiting, diarrhea, abdominal pain, and constipation
Storage and handling Both Toujeo and GLP-1 medications require refrigeration before first use
Diabetes 19934216781682